Prevalence and independent predictors of insulin resistance in children from Crete, Greece: the Children Study

Y Manios1, G Moschonis, G Kourlaba

  • 1Department of Dietetics-Nutrition, Harokopio University, Athens, Greece. manios@hua.gr

Insights

Insulin resistance (IR) is more prevalent in obese children and girls, particularly those with central adiposity. These findings highlight key groups for targeted interventions to prevent Type 2 diabetes and cardiovascular disease.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Insulin resistance (IR) is linked to Type 2 diabetes mellitus and cardiovascular disease.
  • Understanding IR prevalence in children is crucial for early intervention.
  • Greek schoolchildren were studied to assess IR prevalence and associated factors.

Purpose of the Study:

  • Determine the prevalence of insulin resistance in Greek schoolchildren.
  • Identify factors associated with insulin resistance in this population.

Main Methods:

  • Recruited 522 children from Crete between October 2005 and March 2006.
  • Collected data on physical activity, diet, anthropometrics, biochemistry, and parental medical history.
  • Assessed IR using HOMA-IR, FGIR, and QUICKI, with multiple linear regression for predictor analysis.

Main Results:

  • Obese children and girls exhibited higher fasting insulin and HOMA-IR scores, indicating greater insulin resistance.
  • Prevalence of IR was 9.2%, with significantly higher rates in overweight (10.5%) and obese (31.0%) children.
  • Central adiposity, female gender, and simple carbohydrate intake were independent predictors of higher HOMA-IR.

Conclusions:

  • Girls and obese children, especially those with central adiposity, are at elevated risk for insulin resistance.
  • These high-risk groups should be prioritized for preventive strategies against Type 2 diabetes and cardiovascular disease.
Abstract

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...